C.M. Bidwell & Associates’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
C.M. Bidwell & Associates's VCYT Position: Q3 2026 in Review
C.M. Bidwell & Associates reduced its Veracyte (VCYT) stake by 34% in Q3 2026, selling an estimated $1.93K and leaving 78 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #363.
C.M. Bidwell & Associates first reported a position in VCYT in Q1 2019 and has held it in 23 quarters since. The position peaked at $101K in Q1 2019. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- C.M. Bidwell & Associates held 78 shares of Veracyte worth $3.59K as of Q3 2026.
- C.M. Bidwell & Associates sold 40 Veracyte shares in Q3 2026, an estimated $1.93K.
- Veracyte made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q3 2026, its #363 holding.
- C.M. Bidwell & Associates first reported a position in Veracyte in Q1 2019 and has held it in 23 quarters since.
- C.M. Bidwell & Associates's Veracyte position peaked at $101K in Q1 2019.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q3 2026, filed 17 Nov 2026.